SB Technology 

$0.52
0
+$0.05+11.7% Wednesday 13:30

Statistics

Day High
0.52
Day Low
0.52
52W High
-
52W Low
-
Volume
393
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VGLSD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap161.85B
Gilead Sciences is a biopharmaceutical company that competes in the development of treatments similar to VG Life Sciences, focusing on areas such as infectious diseases.
AMGEN
AMGN
Mkt Cap185.74B
Amgen is a biotech firm that competes with VG Life Sciences in the development of innovative therapies and drugs, particularly in the areas of oncology and cardiovascular diseases.
Merck
MRK
Mkt Cap276.38B
Merck & Co. is a global healthcare company that develops pharmaceuticals across various areas, including those that overlap with VG Life Sciences' research interests.
Pfizer
PFE
Mkt Cap153.59B
Pfizer is a pharmaceutical corporation with a broad range of products in various therapeutic areas, competing with VG Life Sciences in the development and marketing of drugs.
Bristol-Myers Squibb
BMY
Mkt Cap119.87B
Bristol-Myers Squibb is a biopharmaceutical company that develops drugs in areas like cancer, competing directly with VG Life Sciences in the oncology sector.
Abbvie
ABBV
Mkt Cap351.47B
AbbVie operates in the pharmaceutical industry, focusing on treatments for conditions in areas such as immunology and oncology, making it a competitor to VG Life Sciences.
Novartis
NVS
Mkt Cap280.79B
Novartis is a global healthcare company that produces drugs in several therapeutic areas, including those that compete with VG Life Sciences' research and development focus.
Roche
RHHBY
Mkt Cap332.61B
Roche Holding AG is a healthcare company that engages in the research and development of pharmaceuticals and diagnostics, competing with VG Life Sciences in the biotechnology and pharmaceutical sectors.
Johnson & Johnson
JNJ
Mkt Cap547.64B
Johnson & Johnson is a diversified healthcare company that develops and sells pharmaceuticals and biopharmaceuticals, competing with VG Life Sciences across multiple therapeutic areas.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.46B
Regeneron Pharmaceuticals is a biotechnology company that develops and commercializes medicines for serious medical conditions, directly competing with VG Life Sciences in the biopharmaceutical field.

About

SB Technology Corp. provides ICT services in Japan. The company offers data analysis and visualization services; security solutions; IT infrastructure solutions; and cloud solutions, as well as creates functional e-commerce sites to operating sites. It is also involved in planning, design, development, and operation of IT systems, mobile apps, and IoT apps. The company was formerly known as SoftBank Technology Corp. and changed its name to SB Technology Corp. in October 2019. The company was founded in 1990 and is headquartered in Tokyo, Japan.
Show more...
CEO
Mr. Shinichi Ata
Employees
1379
Country
Japan
ISIN
US91822T2006

Listings

0 Comments

Share your thoughts

FAQ

What is SB Technology stock price today?
The current price of VGLSD is $0.52 USD — it has increased by +11.7% in the past 24 hours. Watch SB Technology stock price performance more closely on the chart.
What is SB Technology stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange SB Technology stocks are traded under the ticker VGLSD.
How many employees does SB Technology have?
As of April 30, 2026, the company has 1,379 employees.
In which sector is SB Technology located?
SB Technology operates in the Technology sector.
When did SB Technology complete a stock split?
SB Technology has not had any recent stock splits.
Where is SB Technology headquartered?
SB Technology is headquartered in Tokyo, Japan.